104 related articles for article (PubMed ID: 18262286)
1. An antibody-based construct carrying DNA-mimotope and targeting CR1(CD35) selectively suppresses human autoreactive B-lymphocytes.
Voynova E; Tchorbanov A; Prechl J; Nikolova M; Baleva M; Erdei A; Vassilev T
Immunol Lett; 2008 Mar; 116(2):168-73. PubMed ID: 18262286
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous engagement of FcgammaIIb and CD22 inhibitory receptors silences targeted B cells and suppresses autoimmune disease activity.
Mihaylova N; Voynova E; Tchorbanov A; Dolashka-Angelova P; Bayry J; Devreese B; Kaveri S; Vassilev T
Mol Immunol; 2009 Nov; 47(1):123-30. PubMed ID: 19243823
[TBL] [Abstract][Full Text] [Related]
3. Selective silencing of DNA-specific B lymphocytes delays lupus activity in MRL/lpr mice.
Tchorbanov AI; Voynova EN; Mihaylova NM; Todorov TA; Nikolova M; Yomtova VM; Chiang BL; Vassilev TL
Eur J Immunol; 2007 Dec; 37(12):3587-96. PubMed ID: 18034421
[TBL] [Abstract][Full Text] [Related]
4. Elimination of autoreactive B cells in humanized SCID mouse model of SLE.
Kerekov NS; Mihaylova NM; Grozdev I; Todorov TA; Nikolova M; Baleva M; Nikolova M; Prechl J; Erdei A; Tchorbanov AI
Eur J Immunol; 2011 Nov; 41(11):3301-11. PubMed ID: 21830207
[TBL] [Abstract][Full Text] [Related]
5. Target silencing of disease-associated B-lymphocytes by chimeric molecules in SCID model of pristane-induced autoimmunity.
Dimitrova I; Gesheva V; Nikolova K; Mihaylova N; Todorov T; Nikolova M; Tchorbanov A
Lupus; 2010 Oct; 19(11):1261-71. PubMed ID: 20530521
[TBL] [Abstract][Full Text] [Related]
6. Selective silencing of disease-associated B-lymphocytes by chimeric molecules targeting their Fc gamma IIb receptor.
Mihaylova N; Voynova E; Tchorbanov A; Nikolova M; Michova A; Todorov T; Srebreva L; Taskov H; Vassilev T
Int Immunol; 2008 Feb; 20(2):165-75. PubMed ID: 18156625
[TBL] [Abstract][Full Text] [Related]
7. Suppression of allergen-specific B lymphocytes by chimeric protein-engineered antibodies.
Kerekov N; Michova A; Muhtarova M; Nikolov G; Mihaylova N; Petrunov B; Nikolova M; Tchorbanov A
Immunobiology; 2014 Jan; 219(1):45-52. PubMed ID: 24021574
[TBL] [Abstract][Full Text] [Related]
8. Protein-engineered molecules carrying GAD65 epitopes and targeting CD35 selectively down-modulate disease-associated human B lymphocytes.
Manoylov IK; Boneva GV; Doytchinova IA; Mihaylova NM; Tchorbanov AI
Clin Exp Immunol; 2019 Sep; 197(3):329-340. PubMed ID: 31009057
[TBL] [Abstract][Full Text] [Related]
9. Suppression of dsDNA-specific B lymphocytes reduces disease symptoms in SCID model of mouse lupus.
Gesheva V; Kerekov N; Nikolova K; Mihaylova N; Todorov T; Nikolova M; Tchorbanov A
Autoimmunity; 2014 May; 47(3):162-72. PubMed ID: 24502777
[TBL] [Abstract][Full Text] [Related]
10. Selective silencing of autoreactive B lymphocytes-Following the Nature's way.
Nikolova KA; Mihaylova NM; Voynova EN; Tchorbanov AI; Voll RE; Vassilev TL
Autoimmun Rev; 2010 Sep; 9(11):775-9. PubMed ID: 20601201
[TBL] [Abstract][Full Text] [Related]
11. Clearance of anti-double-stranded DNA antibodies: the natural immune complex clearance mechanism.
Craig ML; Bankovich AJ; McElhenny JL; Taylor RP
Arthritis Rheum; 2000 Oct; 43(10):2265-75. PubMed ID: 11037886
[TBL] [Abstract][Full Text] [Related]
12. Anti-DNA Ig peptides promote Treg cell activity in systemic lupus erythematosus patients.
Hahn BH; Anderson M; Le E; La Cava A
Arthritis Rheum; 2008 Aug; 58(8):2488-97. PubMed ID: 18668553
[TBL] [Abstract][Full Text] [Related]
13. Mimotopes for lupus-derived anti-DNA and nucleosome-specific autoantibodies selected from random peptide phage display libraries: facts and follies.
Dieker JW; Sun YJ; Jacobs CW; Putterman C; Monestier M; Muller S; van der Vlag J; Berden JH
J Immunol Methods; 2005 Jan; 296(1-2):83-93. PubMed ID: 15680153
[TBL] [Abstract][Full Text] [Related]
14. Antigen localization within the splenic marginal zone restores humoral immune response and IgG class switch in complement C4-deficient mice.
Zachrau B; Finke D; Kropf K; Gosink HJ; Kirchner H; Goerg S
Int Immunol; 2004 Dec; 16(12):1685-90. PubMed ID: 15477230
[TBL] [Abstract][Full Text] [Related]
15. Complement Receptor Type 1 Suppresses Human B Cell Functions in SLE Patients.
Kremlitzka M; Mácsik-Valent B; Polgár A; Kiss E; Poór G; Erdei A
J Immunol Res; 2016; 2016():5758192. PubMed ID: 27981054
[TBL] [Abstract][Full Text] [Related]
16. Re-establishing tolerance to DNA in humanized and murine models of SLE.
Nikolova K; Mihaylova N; Voynova E; Kerekov N; Gesheva V; Prechl J; Nikolova M; Tchorbanov A
Autoimmun Rev; 2010 May; 9(7):499-502. PubMed ID: 20149897
[TBL] [Abstract][Full Text] [Related]
17. Expression and role of CR1 and CR2 on B and T lymphocytes under physiological and autoimmune conditions.
Erdei A; Isaák A; Török K; Sándor N; Kremlitzka M; Prechl J; Bajtay Z
Mol Immunol; 2009 Sep; 46(14):2767-73. PubMed ID: 19559484
[TBL] [Abstract][Full Text] [Related]
18. Autoreactive anti-DNA transgenic B cells in lupus-prone New Zealand black/New Zealand white mice show near perfect L chain allelic exclusion.
Makdasi E; Fischel R; Kat I; Eilat D
J Immunol; 2009 May; 182(10):6143-8. PubMed ID: 19414767
[TBL] [Abstract][Full Text] [Related]
19. Targeted silencing of DNA-specific B cells combined with partial plasma cell depletion displays additive effects on delaying disease onset in lupus-prone mice.
Nikolova-Ganeva KA; Gesheva VV; Todorov TA; Voll RE; Vassilev TL
Clin Exp Immunol; 2013 Nov; 174(2):221-8. PubMed ID: 23808414
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of cellular FLICE-inhibitory protein in peripheral blood B lymphocytes in patients with systemic lupus erythematosus is associated with clinical characteristics.
Tao J; Dong J; Li Y; Liu YQ; Yang J; Wu Y; Li L; Shen GX; Tan ZJ; Tu YT
J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):433-7. PubMed ID: 19335730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
